TMV-083 Uses, Dosage, Side Effects and more
TMV-083 is an attenuated live virus COVID-19 vaccine candidate which employs the measles vaccine as a vector. It expresses a spike protein antigen from SARS-CoV-2.
| Trade Name | TMV-083 |
| Generic | TMV-083 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
